Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method

Human Reproduction

Volumn 26, Issue 7, 2011, Pages 1708-1714

  Soufir, J C ^a   Meduri, G ^b   Ziyyat, A ^a,c  

^a Institut Cochin   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSTITUT COCHIN   (France)

Author keywords

gonadotrophins; male contraception; medroxyprogesterone; spermatogenesis; testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; SEX HORMONE; TESTOSTERONE;

ADULT; ARTICLE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; HEMATOLOGICAL PARAMETERS; HORMONAL CONTRACEPTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC PARAMETERS; NORMAL HUMAN; PATIENT COMPLIANCE; PREGNANCY; SPERMATOGENESIS; SPERMATOZOON; SPERMATOZOON COUNT; SPERMIOGRAM;

EID: 79959453159     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der138     Document Type: Article

References (34)

1. Amory JK, Page ST, Anawalt BD, Coviello AD, Matsumoto AM, Bremner WJ. Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception. J Androl 2007a;28:548-554 (Pubitemid 47057037)
2. Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ. Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen. Contraception 2007b;75:218-223 (Pubitemid 46217189)
3. Anderson RA, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J Clin Endocrinol Metab 1996;81:896-901
4. Anderson RA, Wallace AM, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J Clin Endocrinol Metab 1996;81:902-908
5. Bain J, Rachlis V, Robert E, Khait Z. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme. Contraception 1980;21:365-379 (Pubitemid 10068919)
6. Buchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 1999;84:1244-1249 (Pubitemid 30644384)
7. Cailleux-Bounacer A, Rohmer V, Lahlou N, Lefebvre H, Roger M, Kuhn JM. Impact level of dihydrotestosterone on the hypothalamic-pituitary-Leydig cell axis in men. Int J Androl 2009;32:57-65
8. Calmeyn S. Notre sondage: du côté des hommes. Reader's Digest Sélection Octobre 2000;49-53
9. Eckardstein SV, Schmidt A, Kamischke A, Simoni M, Gromoll J, Nieschlag E. CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol (Oxf) 2002;57:647-655 (Pubitemid 35316983)
10. Es-Slami S, Marmor D, Soufir JC. Genetic lesions in male gametes and cytotoxic treatments: prevention by hormonal inhibition of spermatogenesis. In Hamamah S, Mieusset R (eds). Research in Male Gametes: Production and Quality. Paris, France: INSERM, 1996,97-107
11. Es-Slami S, Charcellay S, Pinon-Lataillade G, Soufir JC. Short-term pretreatment with medroxyprogesterone and testosterone may potentiate irradiation damage to spermatogenesis in rats. Cancer 1999;85:1313-1322 (Pubitemid 29125085)
12. Fotherby K. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy. Contraception 1996; 54:59-69 (Pubitemid 26256706)
13. Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab 2002;87:3562-3572 (Pubitemid 34879497)
14. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK, Huang ZJ, Zhang GY. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 2003;88:562-568 (Pubitemid 36207791)
15. Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L, Bo L, Xiong C, Wang X, Liu X et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 2009;94:1910-1915
16. Guerin JF, Rollet J. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Int J Androl 1988;11:187-199
17. Hair WM, Kitteridge K, O'Connor DB, Wu FC. A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men. J Clin Endocrinol Metab 2001;86:5201-5209 (Pubitemid 33070236)
18. Handelsman DJ, Farley TM, Peregoudov A, Waites GM. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 1995;63:125-133
19. Hikim AP, Wang C, Lue Y, Johnson L, Wang XH, Swerdloff RS. Spontaneous germ cell apoptosis in humans: evidence for ethnic differences in the susceptibility of germ cells to programmed cell death. J Clin Endocrinol Metab 1998;83:152-156 (Pubitemid 28498327)
20. Lye RJ, Sipila P, Vernet P, Wagenfeld A. Male contraception: a topic with many facets. Mol Cell Endocrinol 2004;216:75-82 (Pubitemid 38520919)
21. Martin CW, Anderson RA, Cheng L, Ho PC, Van der Spuy Z, Smith KB, Glasier AF, Everington D, Baird DT. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 2000;15:637-645 (Pubitemid 30142376)
22. McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW. Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception. Contraception 2000;62:73-78
23. McLachlan RI, O'Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM, Robertson DM. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab 2002;87:546-556 (Pubitemid 34158217)
24. Meriggiola MC, Costantino A, Bremner WJ, Morselli-Labate AM. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl 2002;23:684-690 (Pubitemid 34977525)
25. Nieschlag E. Male hormonal contraception: Love's labour's lost? J Clin Endocrinol Metab 2009;94:1890-1892
26. Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab 2006;91:4374-4380 (Pubitemid 44833412)
27. Rautio A, Saarni HU, Arranto AJ, Stengard JH, Karki NT, Sotaniemi EA. Metabolism of medroxyprogesterone acetate and hepatic drug metabolism activity. Res Commun Chem Pathol Pharmacol 1985;47:305-308 (Pubitemid 15140937)
28. Soufir JC, Laporte A. Efficiency of a male contraceptive association, oral medroxyprogesterone acetate-percutaneous testosterone. In Mario S (ed). IV International Congress of Andrology. Ares-Serono Symposia, Rome, Italy, 1989
29. Soufir JC, Jouannet P, Marson J, Soumah A. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Acta Endocrinol (Copenh) 1983;102:625-632 (Pubitemid 13160953)
30. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 2003; 88:4659-4667 (Pubitemid 37357508)
31. Wang C, Berman NG, Veldhuis JD, Der T, McDonald V, Steiner B, Swerdloff RS. Graded testosterone infusions distinguish gonadotropin negative-feedback responsiveness in Asian and white men: a Clinical Research Center study. J Clin Endocrinol Metab 1998;83:870-876 (Pubitemid 28496459)
32. World Health Organization (WHO). Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Lancet 1990;336:955-959
33. World Health Organization (WHO). Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996;65:821-829
34. World Health Organization (WHO). WHO Laboratory Manual for Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th edn. Cambridge: Cambridge University Press, 1999